Compound hub
CJC-1295
CJC-1295 is a lab-made analogue of growth hormone-releasing hormone. Its published human record is two short trials in healthy adults, reported in 2006, and neither the FDA nor the EMA has approved it as a medicine (Teichman et al., 2006; Dominikowski et al., 2026). This hub answers the questions people ask about CJC-1295 from studies, regulator documents and their stated limits.
Record card
| Common name | CJC-1295 |
|---|---|
| Class | Analogue of growth hormone-releasing hormone (GHRH) |
| Forms | With DAC (albumin-binding hook) and without DAC |
| Human half-life, with DAC | Estimated 5.8 to 8.1 days (Teichman et al., 2006) |
| Published human papers | Three, all in healthy adults (2006, 2006, 2009) |
| Registered phase 2 trial | NCT00267527, terminated, no results posted |
| Approval as a medicine, 2026 | Not approved by FDA or EMA (Dominikowski et al., 2026) |
| Poisons Standard, October 2026 | Schedule 4 and Appendix D clause 5 item 7 (read 1 October 2026 UTC) |
| WADA 2026 list | Class S2.2.4, prohibited at all times |
Questions answered here
06- CJC-1295 side effects: what studies and regulators have recordedCJC-1295 side effects as recorded in published studies and in FDA, TGA and anti-doping documents, and gaps in the sources reviewed. Research material is not a medicine.Updated 2026-10-14
- What does CJC-1295 do? What published studies foundWhat published studies measured about CJC-1295, and the limits of the evidence on muscle, strength, weight and hair. Research material is not a medicine.Updated 2026-10-14
- What is CJC-1295 with DAC? Meaning, forms and evidence statusWhat CJC-1295 with DAC is, what no DAC means, why it is not a steroid or growth hormone, and what studies say on testosterone and insulin. Research material is not a medicine.Updated 2026-10-14
- Tesamorelin vs CJC-1295 vs ipamorelin: what do the studies show?Tesamorelin, CJC-1295 with and without DAC, ipamorelin and hexarelin compared from published studies, FDA labels and regulator records, with the limits of each record. Research material is not a medicine.Updated 2026-10-14
- Is CJC-1295 legal in Australia? TGA, FDA and WADA statusCJC-1295 in the October 2026 Australian Poisons Standard, the TGA's April 2026 advisory, FDA approval and compounding records, and the WADA 2026 list. Dated records, not legal advice.Updated 2026-10-14
- CJC-1295 half-life and pharmacokinetics: what do the studies show?What published studies measured about the half-life of CJC-1295 and of related growth hormone-releasing peptides, how long hormone levels stayed changed in those studies, and gaps in the sources checked for this page. Research material is not a medicine.Updated 2026-10-14
Form Laboratories supplies research-use-only reference material. Everything in this hub is an educational summary of published third-party literature. It is not medical advice, not a use instruction, and research material is not for human or animal use.